Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by IWillRetireSoonon Nov 12, 2014 10:49pm
300 Views
Post# 23123052

RE:AGM filled w details plus potential minor sht-term catalysts

RE:AGM filled w details plus potential minor sht-term catalystsWow this is exciting:
" Current estimate for cost per MCNA dose $3,000 and number of doses 15 to 24. Also mentioned "very high profit margin""

Easy math 20 doses times $3000 = $60,000 per patient.   Did someone say there are 10,000 cases?    Even if only half are eligible for the treatment, I get a number of $300 million. Yet this is only the US numbers.   Thank you Obamacare!   This will get the atttention of big pharma.  
Of course I am certain they will wait for the FDA ruling.    2015 is the year all the long termers will see a return.  
Very positve report.   thanks for sharing. 

<< Previous
Bullboard Posts
Next >>